Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,596,868
  • Shares Outstanding, K 126,553
  • Annual Sales, $ 610,790 K
  • Annual Income, $ -182,630 K
  • EBIT $ -91 M
  • EBITDA $ -48 M
  • 60-Month Beta 2.18
  • Price/Sales 3.94
  • Price/Cash Flow N/A
  • Price/Book 3.19

Options Overview Details

View History
  • Implied Volatility 81.56% (+5.28%)
  • Historical Volatility 54.32%
  • IV Percentile 50%
  • IV Rank 40.05%
  • IV High 127.16% on 04/23/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 2) 1.22 (5.94%)
  • Put/Call Vol Ratio 3.73
  • Today's Volume 52
  • Volume Avg (30-Day) 468
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 12,125
  • Open Int (30-Day) 10,213
  • Expected Range 19.25 to 21.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.20
  • Number of Estimates 8
  • High Estimate -0.13
  • Low Estimate -0.27
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.18 +34.82%
on 12/15/25
21.18 -3.38%
on 01/12/26
+5.01 (+32.37%)
since 12/12/25
3-Month
11.62 +76.12%
on 10/15/25
21.18 -3.38%
on 01/12/26
+8.93 (+77.34%)
since 10/14/25
52-Week
6.78 +201.84%
on 04/07/25
21.18 -3.38%
on 01/12/26
+5.03 (+32.55%)
since 01/14/25

Most Recent Stories

More News
1 Cash-Heavy Stock to Consider Right Now and 2 We Question

1 Cash-Heavy Stock to Consider Right Now and 2 We Question

DDS : 681.45 (-2.68%)
TXG : 20.59 (+0.34%)
ISRG : 533.57 (-5.03%)
Why 10x Genomics (TXG) Shares Are Falling Today

Why 10x Genomics (TXG) Shares Are Falling Today

TXG : 20.59 (+0.34%)
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care

TXG : 20.59 (+0.34%)
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power...

TXG : 20.59 (+0.34%)
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generation...

TXG : 20.59 (+0.34%)
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

PLEASANTON, Calif. , Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth...

TXG : 20.59 (+0.34%)
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling

TXG : 20.59 (+0.34%)
CDNA : 20.35 (+0.79%)
10x Genomics (TXG) Stock Is Up, What You Need To Know

10x Genomics (TXG) Stock Is Up, What You Need To Know

TXG : 20.59 (+0.34%)
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid

2 Russell 2000 Stocks Worth Investigating and 1 We Avoid

TXG : 20.59 (+0.34%)
MMS : 96.15 (-0.09%)
HIMS : 31.46 (-2.30%)
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif. , Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc.  (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present...

TXG : 20.59 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 22.23
2nd Resistance Point 21.48
1st Resistance Point 21.00
Last Price 20.59
1st Support Level 19.77
2nd Support Level 19.02
3rd Support Level 18.54

See More

52-Week High 21.18
Last Price 20.59
Fibonacci 61.8% 15.68
Fibonacci 50% 13.98
Fibonacci 38.2% 12.28
52-Week Low 6.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar